Meliora Therapeutics
The AI engine Fit Assessment
BetaMeliora Therapeutics leverages machine learning to discover new drug mechanisms and expand therapeutic options, optimizing the drug discovery process.
Blurb
Meliora Therapeutics is a biotech startup that is developing a machine learning-driven platform.
HQ Location
San Francisco (United States)
Founded
2021
Employees
11 - 50
Total funding raised
$11.00M
Last Funding Event
Seed, $11.00M, September 29, 2022
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Drug Discovery Optimization
Operator of a next-generation biotech company intended to develop life-saving cancer therapies using machine learning. The company uses a proprietary prediction atlas mapping drug mechanism to identify the true MOA of molecules of interest cutting out a large and expensive phase of time, enabling researchers to ramp up the drug development process.